Table 3.
Factors Associated With Newly Diagnosed HCV Among Medicaid Beneficiaries With SUD Who Received HCV Testing Using a Multivariable Logistic Model
| Factors | HCV (N=2,177)a AOR (95% CI) |
|---|---|
|
| |
| Race | |
| White versus Black | 2.71 (2.38, 3.08) |
| Hispanic versus Non-Hispanic | 0.45 (0.35, 0.58) |
| Male versus female | 1.49 (1.35, 1.66) |
| Age (ref: 51–64 years)b | |
| 18–35 years | 0.61 (0.54, 0.69) |
| 36–50 years | 0.63 (0.55, 0.71) |
| Clinical conditionsc | |
| Pregnancy | 1.34 (1.14, 1.57) |
| HIV | 0.77 (0.57, 1.03) |
| Cirrhosis | 1.79 (1.36, 2.35) |
| Hepatitis B virus | 2.60 (1.66, 4.08) |
| Smoking | 1.05 (0.95, 1.16) |
| Type of SUD (ref: other substances alone) | |
| Alcohol alone | 1.17 (1.02, 1.33) |
| Opioid alone | 1.82 (1.59, 2.09) |
| Opioid + alcohol | 1.50 (1.12, 2.00) |
| Other substances + alcohol | 1.63 (1.31, 2.04) |
| Other substances + opioid | 3.38 (2.88, 3.96) |
| Other substances + opioid+ alcohol | 2.05 (1.47, 2.85) |
| Behaviorsc | |
| Receipt of blood transfusion | 0.86 (0.68, 1.09) |
| Receipt of HIV test | 1.33 (1.17, 1.52) |
| Receipt of syringe with sterile needle | 1.23 (0.56, 2.72) |
| Receipt of psychotherapy | 1.00 (0.88, 1.14) |
| SUD treatment | 2.18 (1.89, 2.53) |
| Number of HCV testing | 0.88 (0.83, 0.94) |
a
Either acute or chronic HCV; 83 patients diagnosed with acute HCV developed chronic HCV. When the authors calculated the number of cases of either acute or chronic HCV, this study deleted the 83 duplicates, ending up with 2,177 patients.
b
Age was measured at the date when patients with SUD received the first HCV testing.
c
Clinical conditions and patient behaviors were measured 1 year before the first HCV testing after patients were newly diagnosed with SUD.
HCV, hepatitis C virus; SUD, substance use disorders.